More Education

Blog Pharmacists Poised to Play Larger Role in Uptake of Biosimilars

With the backing of new laws, retail pharmacists have considerable freedom to switch patients to FDA approved interchangeable biosimilars. While most are willing to use that freedom, according to a new report, unanswered questions remain.

Read More

Related Content

Paper Focus on Access: Navigating Medicare Part B Negotiation and Its Unintended Consequences Brief

Paper What Patients Should Know About Biologics

Event Report AfPA’s 2024 National Policy & Advocacy Summit Report

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below:

(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';fnames[1]='FNAME';ftypes[1]='text';fnames[2]='LNAME';ftypes[2]='text';}(jQuery));var $mcj = jQuery.noConflict(true);